Richard Olney Next Generation Clinician Scientist Grant in ALS
Richard Olney Next Generation Clinician Scientist Grant in ALS supports early-career clinician-investigators studying ALS mechanisms, diagnosis, or treatment to advance clinically relevant research.
Browse similar grants
Funder: American Brain Foundation
Due Dates: October 8, 2026, at 5:00 PM CT (Application and all supporting materials)
Funding Amounts: $240,000 over three years ($80,000 per year)
Summary: Supports early-career clinician-investigators conducting clinical or preclinical research on ALS mechanisms, diagnosis, or treatment.
Key Information: Applicants must have completed clinical residency or a PhD in 2020 or later and have 70% protected research time.
Description
The Richard Olney grant supports early-career clinician-investigators pursuing clinical or preclinical research in amyotrophic lateral sclerosis (ALS). Funded jointly by The ALS Association and the American Brain Foundation and administered by the foundation, this three-year award supports work on disease mechanisms, diagnosis, or treatment, particularly research with potential relevance beyond ALS.
The grant is part of the foundation’s Next Generation Research Grants program and reflects its Cure One, Cure Many philosophy: breakthroughs in one brain disease can accelerate progress in others. Priorities include rigorous, innovative science, a clear and testable hypothesis, clinical impact, and translational value. Mentorship and career development are central to helping recipients move toward research independence. The foundation also encourages broad perspectives and study populations reflecting the full spectrum of people affected by ALS.
